Showing results (231-240 of 491) with videos related to

Sort By:
Pageof 50
Journal of the American Academy of Child and Adolescent Psychiatry|March 21, 2015
Psychiatric disorders and violence: a study of delinquent youth after detentionKatherine S Elkington, Linda A Teplin, Karen M Abram, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|November 19, 2011
Disseminated Mycobacterium marinum infection in a hematopoietic stem cell transplant recipientS Jacobs, A George, G A Papanicolaou, et al.
The Journal of Biological Chemistry|June 16, 1995
Differential activation of cytosolic phospholipase A2 (cPLA2) by thrombin and thrombin receptor agonist peptide in human platelets. Evidence for activation of cPLA2 independent of the mitogen-activated protein kinases ERK1/2R M Kramer, E F Roberts, P A Hyslop, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 8, 2016
Colorectal carcinomas with submucosal invasion (pT1): analysis of histopathological and molecular factors predicting lymph node metastasisReetesh K Pai, Yu-Wei Cheng, Maureen A Jakubowski, et al.
Bone Marrow Transplantation|January 17, 2017
Long term renal survival in patients undergoing T-Cell depleted versus conventional hematopoietic stem cell transplantsI G Glezerman, S Devlin, M Maloy, et al.
Thrombosis and Haemostasis|December 22, 2011
Comparison of a new ELISA assay with the flow cytometric assay for platelet vasodilator-associated stimulated phosphoprotein (VASP) phosphorylation in whole blood to assess P2Y(12) inhibitionJoseph A Jakubowski, Nicolas Bourguet, Danièle Boulay-Moine, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 8, 2010
Hepatic safety of voriconazole after allogeneic hematopoietic stem cell transplantationI Amigues, N Cohen, D Chung, et al.
European Journal of Pharmacology|November 13, 2007
Repeat oral dosing of prasugrel, a novel P2Y12 receptor inhibitor, results in cumulative and potent antiplatelet and antithrombotic activity in several animal speciesYoichi Niitsu, Atsuhiro Sugidachi, Taketoshi Ogawa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1989
Phase I trial of intramuscularly administered tumor necrosis factor in patients with advanced cancerA A Jakubowski, E S Casper, J L Gabrilove, et al.
The Journal of Laboratory and Clinical Medicine|December 18, 2002
Ethanol enhances the inhibitory effect of an oral GPIIb/IIIa antagonist on human platelet functionMargaret L Rand, Joseph A Jakubowski, Matthew J Fisher, et al.
Pageof 50